NASDAQ$HCAT
Health Catalyst Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Achieved strong performance, exceeding revenue and Adjusted EBITDA guidance, and reached positive quarterly Adjusted EBITDA for the first time since incorporation.
Health Catalyst reported strong second-quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive quarterly Adjusted EBITDA for the first time and closed the acquisition of Twistle, which is expected to enhance the Population Health analytics application suite.
- Achieved strong performance across the business in Q2 2021.
- Exceeded the mid-point of quarterly guidance for both revenue and Adjusted EBITDA.
- Achieved positive quarterly Adjusted EBITDA for the first time since the company’s incorporation.
- Closed the acquisition of Twistle on July 1, 2021, to bolster the Population Health analytics application suite.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$59.6M
Revenue by segment
Health Catalyst · $59.6M total across 2 segments · Q2 2021
- Technology$35.5M—59.6%
- Professional Services$24.1M—40.4%
Forward guidance
Health Catalyst provided revenue guidance between $59.4 million and $62.4 million and Adjusted EBITDA between $(7.5) million and $(5.5) million for Q3 2021. For the full year 2021, the company expects revenue between $236.7 million and $239.7 million and Adjusted EBITDA between $(12.5) million and $(10.5) million.
Tailwinds
- Total revenue between $59.4 million and $62.4 million for Q3 2021
- Adjusted EBITDA between $(7.5) million and $(5.5) million for Q3 2021
- Total revenue between $236.7 million and $239.7 million for the full year of 2021
- Adjusted EBITDA between $(12.5) million and $(10.5) million for the full year of 2021
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2021
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro